Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Amortization of Goodwill (2025)

Harvard Bioscience (HBIO) reported Amortization of Goodwill of $48.0 million for Q1 2025.

Harvard Bioscience (HBIO) has 1 years of Amortization of Goodwill data on file, last reported at $48.0 million in Q1 2025.

  • Quarterly Amortization of Goodwill changed N/A year-over-year to $48.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $48.0 million (changed N/A YoY) and the FY2025 annual result came in at $48.0 million, changed N/A from the prior year.
  • Amortization of Goodwill was little changed at $48.0 million in Q1 2025 per HBIO's latest filing.
  • Across five years, Amortization of Goodwill topped out at $48.0 million in Q1 2025 and bottomed at $48.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 48.00 Mn
Mar 31, 2025 48.00 Mn